Focal therapy of localized prostate cancer is a very attractive treatment option since it has the potential for curing a man while minimizing risk and complications.
Miami, Florida (PRWEB) May 29, 2013
Bert Vorstman MD, MS, FAAP, FRACS, FACS is a leading specialist in the management of localized prostate cancer employing minimally invasive and focal therapy techniques as well as active surveillance monitoring. He has posted his latest blog entitled, “Focal Treatment of Early Prostate Cancer” on his Uro Health Blog site.
“Focal therapy of localized prostate cancer is a very attractive treatment option since it has the potential for curing a man while minimizing risk and complications. Focal treatment results are in sharp contrast to the current whole gland treatments with options such as the high-risk, irreversible radical surgery/robotic prostatectomy where there are very significant risks and no significant lives saved,” said Dr Bert Vorstman, a Coral Springs Florida urologist with over 30 years of experience in the management of localized prostate cancer. Dr Vorstman cautioned however, ‘Most prostate cancers are classed as favorable-risk Gleason 6 (3+3) prostate cancers and most of these may not need any treatment at all. The majority of men with localized favorable-risk Gleason 3+3 prostate cancer will outlive their cancer as it has a very long natural history and this type of prostate cancer tends not to progress. Except for men with high-risk prostate cancer which demands treatment, most men with Gleason 3+3 prostate cancers should simply undergo active surveillance through periodic monitoring.”
Dr Vorstman’s passion is the empowerment of men and their wives/partners about prostate cancer, management options and health choices. He is an outspoken patient advocate and a critic of overdiagnosis and overtreatment of favorable-risk Gleason 3+3 prostate cancers. His powerful messages and insights about prostate cancer reach many people through his website and blog, http://www.urologyweb.com
To review Dr Vorstman’s complete works on localized prostate cancer treatment and management go to http://www.urologyweb.com/exclusive-medical-reports/ or contact Dr Bert Vorstman at 877 783 4438 or, bvorstmanmd(at)gmail(dot)com